TipRanks
Hikma Pharmaceuticals PLC (DE:H5P)
FRANKFURT:H5P
Germany Market

Hikma Pharmaceuticals (H5P) Technical Analysis

4 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Hikma Pharmaceuticals PLC’s (H5P) Moving Averages Convergence Divergence (MACD) indicator is -0.16, suggesting Hikma Pharmaceuticals PLC is a Buy.
Hikma Pharmaceuticals PLC’s (H5P) 20-Day exponential moving average is 18.39, while Hikma Pharmaceuticals PLC’s (H5P) share price is €18.92, making it a Sell.
Hikma Pharmaceuticals PLC’s (H5P) 50-Day exponential moving average is 18.25, while Hikma Pharmaceuticals PLC’s (H5P) share price is €18.92, making it a Buy.

Hikma Pharmaceuticals (H5P) Pivot Points

Sep 18, 2026, 01:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.39
17.65
17.78
18.04
18.17
18.43
18.56
Fibonacci
17.65
17.80
17.89
18.04
18.19
18.28
18.43
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Hikma Pharmaceuticals (H5P) Moving Averages

Sep 18, 2026, 01:58 PM
Period
Simple
Exponential
MA5
17.85Buy
18.06Buy
MA10
18.25Buy
18.20Buy
MA20
18.61Sell
18.39Sell
MA50
18.44Sell
18.25Buy
MA100
17.55Buy
17.76Buy
MA200
16.80Buy
17.50Buy
Hikma Pharmaceuticals PLC’s (H5P) 10-Day exponential moving average is 18.20, while Hikma Pharmaceuticals PLC’s (H5P) share price is €18.92, making it a Buy.
Hikma Pharmaceuticals PLC’s (H5P) 100-Day exponential moving average is 17.76, while Hikma Pharmaceuticals PLC’s (H5P) share price is €18.92, making it a Buy.
Hikma Pharmaceuticals PLC’s (H5P) stock price is €18.92 and Hikma Pharmaceuticals PLC’s (H5P) 50-day simple moving average is 18.44, creating a Sell signal.
Hikma Pharmaceuticals PLC’s (H5P) stock price is €18.92 and Hikma Pharmaceuticals PLC’s (H5P) 100-day simple moving average is 17.55, creating a Buy signal.
Hikma Pharmaceuticals PLC’s (H5P) stock price is €18.92 and Hikma Pharmaceuticals PLC’s (H5P) 200-day simple moving average is 16.80, creating a Buy signal.

Hikma Pharmaceuticals (H5P) Technical Indicators

Sep 18, 2026, 01:58 PM
Name
Value
Implied Action
RSI (14)
48.45
Neutral
STOCH (9,6)
48.58
Neutral
STOCHRSI (14)
40.18
Neutral
MACD (12,26)
-0.16
Buy
ADX (14)
18.21
Buy
Williams %R
-43.78
Buy
CCI (14)
-81.66
Neutral
ATR (14)
0.35
-
Ultimate Oscillator
37.36
Neutral
ROC
-4.09
Sell
Hikma Pharmaceuticals PLC’s (H5P) Relative Strength Index (RSI) is 48.45, creating a Neutral signal.
Hikma Pharmaceuticals PLC’s (H5P) Trend Strength Indicator (ADX) is 18.21, creating a Buy signal.
Hikma Pharmaceuticals PLC’s (H5P) Commodity Channel Index (CCI) is -81.66, creating a Neutral signal.
Hikma Pharmaceuticals PLC’s (H5P) Price Rate of Change (ROC) is -4.09, creating a Sell signal.

FAQ

Is H5P a Buy, Hold, or Sell?
Based on H5P’s technical indicators, H5P is a Buy.
    What is H5P’s RSI (14)?
    H5P’s RSI (14) is 48.45, which suggests H5P is a Neutral.
      What is H5P’s MACD?
      H5P’s MACD is -0.16, which suggests H5P is a Buy.
        What is H5P’s 5-day moving average?
        H5P’s 5-day moving average is 17.85, which suggests H5P is a Buy.
          What is H5P’s 20-day moving average?
          H5P 20-day moving average is 18.61, which suggests H5P is a Sell.
            What is H5P’s 50-day moving average?
            H5P’s 50-day moving average is 18.44, which suggests H5P is a Sell.
              What is H5P’s 200-day moving average?
              H5P’s 200-day moving average is 16.80, which suggests H5P is a Buy.
                What is H5P’s Williams % R (14)?
                H5P’s Williams % R (14) is -43.78, which suggests H5P is a Buy.
                  What is H5P’s CCI (14)?
                  H5P’s CCI (14) is -81.66, which suggests H5P is a Neutral.
                    What is the share price of Hikma Pharmaceuticals PLC?